4-((1,3,4-Thiadiazol-2-yl)amino)-4-oxobutanoic acid

Catalog No. :
ACFPYM263
CAS No. :
26861-97-2
Molecular Formula :
C6H7N3O3S
Molecular Weight :
201.21

IUPAC Name:4-((1,3,4-thiadiazol-2-yl)amino)-4-oxobutanoic acid

4-((1,3,4-Thiadiazol-2-yl)amino)-4-oxobutanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$97.00Login to see priceInquiryInquiry
1g95%$214.00Login to see priceInquiryInquiry
5g95%$795.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-((1,3,4-Thiadiazol-2-yl)amino)-4-oxobutanoic acid
IUPAC Name4-((1,3,4-thiadiazol-2-yl)amino)-4-oxobutanoic acid
MDL No.MFCD01357643
Molecular FormulaC6H7N3O3S
Molecular Weight201.21
SMILESO=C(O)CCC(NC1=NN=CS1)=O
InChI KeyJYLCXMIWSXYXNE-UHFFFAOYSA-N
Synonym4-OXO-4-(1,3,4-THIADIAZOL-2-YLAMINO)BUTANOIC ACID;4-oxo-4-(1,3,4-thiadiazol-2-ylamino)butanoic acid(SALTDATA: FREE);CHEMBRDG-BB 4022677;Butanoic acid, 4-oxo-4-(1,3,4-thiadiazol-2-ylamino)-;4-((1,3,4-Thiadiazol-2-yl)amino)-4-oxobutanoic acid
CAS No.26861-97-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACFPYM263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKOTL573 route compound structure diagram
    ACKOTL5734005-51-0 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFPYM263 route product structure diagram
    ACFPYM26326861-97-2
Inquiry

2. ACFPYM263 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFPYM263 route product structure diagram
    ACFPYM26326861-97-2
Inquiry

Comments (0)